A subdural hematoma is a collection of blood in the subdural space between the dura mater and the meninges within the skull. This condition occurs as a result of rupture of veins, which may be due to both traumatic and nontraumatic impacts. Subdural hematomas may present acutely or chronically, depending on the time elapsed since the injury or initial occurrence. Clinical manifestations range from mild neurological deficits to profound impairment of consciousness or even death. This disease is a serious neurological problem, especially in elderly patients and those with impaired coagulation.
History of the disease and interesting historical facts
Subdural hematomas have been known to medicine since ancient times. The first written references to this condition can be found in the treatises of Hippocrates, who described head injuries and their consequences. However, the modern understanding of subdural hematomas began to form after the development of neurosurgery in the 19th century. In 1905, German neurosurgeon Friedrich Scherer invented a method of surgical intervention for the removal of hematomas, which marked the beginning of a new stage in the treatment of this pathology. Interestingly, in the 20th century, the number of spontaneous cases of subdural hematoma increased significantly due to the expansion of indications for computed tomography, which made it possible to diagnose diseases that could previously remain unnoticed in time.
Epidemiology
The incidence of subdural hematoma varies depending on the age group, the presence of concomitant diseases and the lifestyle of the patients. According to epidemiological studies, the incidence among the elderly (>65 years) is significantly higher and reaches 1.5 per 1000 people per year. Current data show that there is an approximately equal ratio among men and women, but in men, against the background of alcohol dependence, the risk of developing the disease increases significantly. Increased incidence is also noted in patients with reduced blood coagulation, including those taking anticoagulant drugs.
Genetic predisposition to this disease
There are currently no clearly identified genes or mutations that are directly associated with decreased resistance to subdural hematomas. However, it should be noted that certain inherited disorders that cause hemostatic disorders may increase the risk of developing this disease. Research suggests that genetic factors that affect blood clotting, including mutations in genes that affect clotting factors, may lead to an increased susceptibility to subdural hematomas. Examples of such disorders include inherited thrombophilias such as factor V Leyden mutation and antithrombin III deficiency.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of a subdural hematoma. The main ones include:
- Head injuries, especially from falls or sports injuries.
- Age: Older patients have poorer vascular stability and are more likely to fall.
- Alcohol dependence, which promotes and reduces concentration, which can lead to injury.
- Coagulation disorders or taking anticoagulant drugs, which can contribute to the formation of hematomas.
- Microangiopathy seen in diabetes and hypertension.
Diagnosis of this disease
Diagnosis of subdural hematoma involves many methods and stages. The main symptoms that specialists pay attention to may include:
- Headache: may be acute or chronic.
- Impaired consciousness: from mild confusion to deep coma.
- Neurological disorders: such as paralysis, dysarthria, sensory impairment.
- Changes in behavior or personality, which is more common in the chronic form.
Laboratory tests, such as blood tests for coagulation and platelet counts, can help evaluate the patient's overall condition. Radiologic tests, including computed tomography (CT) and magnetic resonance imaging (MRI), are the primary imaging modalities to accurately diagnose the presence of a hematoma and determine its size. Other diagnostic tests, including angiography, are also considered and may be helpful if associated vascular abnormalities are suspected. It is important to differentiate other conditions, such as epidural hematoma, ischemic strokes, and other neurologic disorders.
Treatment
Treatment of subdural hematoma may vary depending on the patient's age, presence of comorbidities, and size of the hematoma. General management includes observation if the hematoma is small and the patient is stable. Pharmacological treatment may include corticosteroids to reduce cerebral edema and drugs to correct coagulation. Surgical treatment, including debulking the hematoma or creating a craniotomy for drainage, is often required in cases of acute hematomas or progression of symptoms. Other treatments include physical therapy and rehabilitation to restore neurological function.
List of medications used to treat this disease
Medications used to treat subdural hematoma may include:
- Corticosteroids (eg, dexamethasone) to reduce swelling.
- Medicines for normalizing blood clotting (for example, vitamin K to correct anticoagulant therapy).
- Painkillers for pain relief.
- Neuroprotectors (eg, actovegin) to improve neuronal metabolism.
Disease monitoring
Monitoring of patients with subdural hematoma should be careful and regular. This includes monitoring of the neurological status and dynamic CT to assess changes in the size of the hematoma. The prognosis with adequate and timely treatment can be favorable, but complications such as recurrent hematoma or development of post-traumatic epilepsy are possible, which can significantly worsen the patient's quality of life.
Age-related features of the disease
Subdural hematoma is especially common among elderly patients, where it may develop due to the natural aging of blood vessels and frequent falls. In children, subdural hematomas often occur as a result of injuries associated with physical activity. In young people and adults, traumatic hematomas are more often observed after road traffic accidents. At each age, the disease has its own clinical course and requires an individual approach to treatment.
Questions and Answers
- What are the symptoms of a subdural hematoma? Symptoms may include headache, confusion, neurological disorders, and behavioral changes.
- How is subdural hematoma diagnosed? Diagnosis includes clinical evaluation, laboratory tests, and radiological tests such as CT and MRI.
- What is the treatment for subdural hematoma? Treatment may include observation, medication, and surgery to remove the hematoma.
- Who is at risk for developing a subdural hematoma? Those at risk include the elderly, alcoholics, patients with coagulation disorders and chronic diseases.
- What is the prognosis for patients with subdural hematoma? The prognosis depends on the size of the hematoma and the timeliness of treatment; in general, good outcomes are possible with adequate therapy.
